NYSE · Insurance - Life · USD
MetLife, Inc. (MET) Stock Analysis
MetLife, Inc. (MET) is a Insurance - Life stock listed on NYSE and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
MET Key Statistics
As of Oct 21, 2026Trading
- Open
- $101.86
- Previous Close
- $101.18
- Day's Range
- 101.62–102.57
- 52-Week Range
- 67.33–102.57
- Volume
- 2.91M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.78
Valuation
- Market Cap
- $64.93B
- P/E Ratio
- 19.57
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 9.16
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 0.53
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 0.82
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 5.22
Financials (FY)
- Revenue (FY)
- $75.65B+7.88%
- Net Income (FY)
- $3.38B−23.66%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 4.57%
- Shares Outstanding
- 635.48M
- 1-Year Return
- +33.00%
Dividend and dates
- Dividend
- $2.37+2.34%
- Ex-Dividend Date
- November 3, 2026
- Earnings Date
- November 4, 2026
- Avg Volume
- 3.33M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, MET closed at $102.18, +33.00% over 1 year.
MetLife, Inc. (MET) has a market capitalization of $64.93B.
In fiscal 2025, MET reported revenue of $75.65B.
MET Stock Return by Calendar Year
MetLife, Inc. (MET) 10-year return: what $10,000 became
- 1 year
- $10,000 $13,300
- +33.00%
- 5 years
- $10,000 $18,049
- +80.49%
- 10 years
- $10,000 $34,533
- +245.33%
If you had invested $10,000 in MetLife, Inc. (MET) 10 years ago, at the close on October 21, 2016, it would have been worth $34,533 at the close on October 21, 2026: +245.33% in total, +13.19% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +32.18% |
| 2025 | −0.80% |
| 2024 | +27.68% |
| 2023 | −5.49% |
| 2022 | +19.23% |
| 2021 | +37.43% |
| 2020 | −3.42% |
| 2019 | +28.84% |
| 2018 | −15.77% |
| 2017 | +8.42% |
| 2016 (partial year) | +31.11% |
As of October 21, 2026.
MET Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $75.65B | $3.38B | 4.5% |
| 2024 | $70.13B | $4.43B | 6.3% |
| 2023 | $67.93B | $1.58B | 2.3% |
| 2022 | $67.41B | $5.28B | 7.8% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $75.65B | — | — | $3.38B | 4.5% |
| 2024 | $70.13B | — | — | $4.43B | 6.3% |
| 2023 | $67.93B | — | — | $1.58B | 2.3% |
| 2022 | $67.41B | — | — | $5.28B | 7.8% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
MET Dividend History
Dividends per share, 2025 · 4 payments
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026* | $1.75 | 3 | — |
| 2025 | $2.25 | 4 | +4.4% |
| 2024 | $2.16 | 4 | +4.6% |
| 2023 | $2.06 | 4 | +4.0% |
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026 (partial year) | $1.75 | 3 | — |
| 2025 | $2.25 | 4 | +4.4% |
| 2024 | $2.16 | 4 | +4.6% |
| 2023 | $2.06 | 4 | +4.0% |
| 2022 | $1.98 | 4 | +4.2% |
| 2021 | $1.90 | 4 | +4.4% |
| 2020 | $1.82 | 4 | +4.6% |
| 2019 | $1.74 | 4 | +4.8% |
| 2018 | $1.66 | 4 | +13.0% |
| 2017 | $1.47 | 4 | +312.2% |
| 2016 | $0.36 | 1 | — |
Most recent payment: $0.58 per share, ex-dividend August 4, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.
MET Valuation vs Insurance - Life Median
Median of 22 stocks| Metric | MET | Insurance - Life median | vs median |
|---|---|---|---|
| P/E | 19.57 | 12.18 | 61% above |
| P/S ratio | 0.82 | 1.10 | 26% below |
| Profit margin | 4.57% | 8.74% | 4.2 pts below |
Medians across 22 Insurance - Life stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
The Zacks Analyst Blog Highlights Sun Life Financial, Coca-Cola, Altria, Keurig Dr Pepper and MetLife
YahooMetLife's ChatGPT Integration Opens a New Pet Insurance Growth Avenue
YahooBetter Dividend Stock for Retirees: Prudential vs. MetLife
TIKRJP Morgan Maintains Overweight on MetLife, Raises Price Target to $110
BenzingaMetLife Brings Pet Insurance to ChatGPT, Expanding How Consumers Research, Quote and Fetch Coverage Through AI
YahooWells Fargo Maintains Overweight on MetLife, Raises Price Target to $110
Benzinga
All 20 articles ↓Show fewer ↑
Metlife Fixed Rate Preferreds: Strong Yield But With High Interest Rate Exposure
SeekingAlphaTranscript: MetLife Q2 2026 Earnings Conference Call
BenzingaMetLife to Announce Third Quarter 2026 Results
YahooMizuho Maintains Outperform on MetLife, Lowers Price Target to $109
BenzingaA Record 95% of Sponsors With De-Risking Goals Intend to Fully Divest Their Pension Liabilities, MetLife Poll Finds
YahooBarclays Maintains Overweight on MetLife, Raises Price Target to $111
BenzingaMetLife Declares Fourth Quarter 2026 Common Stock Dividend
YahooMetLife and Charm Team Up to Protect People and Build Stronger Communities
Yahoo'Prudential Mexico, Brazil Units Draw Interest from MetLife, CNP' - Bloomberg
BenzingaUBS Maintains Buy on MetLife, Raises Price Target to $110
BenzingaTD Cowen Maintains Buy on MetLife, Raises Price Target to $110
BenzingaMetLife Anticipates Q3 Variable Investment Income Of At Least $600M Pre-Tax, FY26 Guidance For Variable Investment Income Of ~$1.60B Pre-Tax
BenzingaCan MetLife's Group Benefits Segment Maintain Its Momentum?
YahooPiper Sandler Upgrades MetLife to Overweight, Raises Price Target to $110
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Insurance - Life Stocks
Great-West Lifeco Inc.
CA$82.20B
MFCManulife Financial Corporation
$74.87B
AFLAflac Incorporated
$60.24B
POW.TOPower Corporation of Canada
CA$59.33B
PRUPrudential Financial, Inc.
$39.61B
PUKPrudential plc
$29.97B
Popular Financial Services Stocks
Berkshire Hathaway Inc.
$1.11T
JPMJPMorgan Chase & Co.
$890.13B
VVisa Inc.
$765.68B
MAMastercard Incorporated
$545.42B
BACBank of America Corporation
$358.24B














